Rosetta Genomics (ROSG) Sets New 52-Week Low at $0.53
Shares of Rosetta Genomics Ltd. (NASDAQ:ROSG) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $0.53 and last traded at $0.63, with a volume of 154400 shares trading hands. The stock had previously closed at $0.65.
The company has a current ratio of 2.10, a quick ratio of 2.10 and a debt-to-equity ratio of 0.03.
TRADEMARK VIOLATION NOTICE: This article was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/rosetta-genomics-rosg-sets-new-52-week-low-at-0-53/1766238.html.
About Rosetta Genomics
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).
Receive News & Ratings for Rosetta Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics and related companies with MarketBeat.com's FREE daily email newsletter.